Autoimmune

Ankylosing Spondylitis: Diagnosis & Treatment

Ankylosing spondylitis causes inflammatory back pain and progressive spinal stiffening, typically starting in young adulthood. Early diagnosis and treatment prevent long-term disability.

Peak onset
Late teens to 30s
Male:female ratio
~3:1 (though under-diagnosed in women)
Key test
HLA-B27 (present in ~90%)
Treatment
Biologics highly effective

Inflammatory Back Pain Features

Diagnostic Tests

TestPurpose
HLA-B27Present in ~90% of AS patients — supports diagnosis but not diagnostic alone (8% of general population also carry it)
ESR/CRPMay be raised, but normal doesn't exclude AS
MRI sacroiliac jointsCan show inflammation years before X-ray changes
X-ray spine/pelvisShows characteristic changes in established disease

Treatment

StepTreatment
First-lineNSAIDs regularly, plus physiotherapy and exercise
If inadequate responseBiologic therapy (TNF inhibitors like adalimumab, etanercept)
Newer optionIL-17 inhibitors (secukinumab)
Exercise Is Essential TreatmentRegular exercise, particularly extension and stretching exercises, is as important as medication in AS — it maintains spinal mobility and reduces the risk of progressive stiffening and fusion.
Does everyone with HLA-B27 get ankylosing spondylitis?
No — only about 5% of HLA-B27 positive people develop AS. It's a risk marker, not a diagnosis on its own.
Can ankylosing spondylitis affect other body parts?
Yes — it can affect the eyes (uveitis), causing eye pain and redness, and rarely the heart and lungs in longstanding disease.
Medical Disclaimer: This page is for general education only and does not replace professional medical advice. Always consult a qualified healthcare provider.